Prime Medicine is cutting its pipeline, but gaining a partner.
The gene editing company, which once boasted a pipeline of 18 programs, is now focusing …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Good morning, everyone, to another working week. We hope the weekend respite was relaxing and inspiring, because that oh-so familiar routine of online meetings, deadlines,
Critical Path Institute (C-Path) today announced the formation of a new task force under its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), dedicated to
Researchers at the University of Illinois at Urbana-Champaign have shown for the first time that expensive aberration-corrected microscopes are no longer required to achieve record-breaking